Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Parmax Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

₹46

2024-10-29

Market Capitalization

₹172.5 M

2024-10-29

Revenue

₹282 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

INRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue119.0M120.1M209.3M262.0M182.5M154.2M110.5M282.0M
Cost of goods sold59.7M53.0M115.6M137.6M70.7M57.2M71.6M215.8M
Gross profit59.8M67.5M94.0M124.7M112.1M97.3M39.3M66.5M
Gross profit margin, %56.2%44.9%47.6%61.4%63.1%35.5%23.6%
Operating expense total48.5M55.8M75.8M90.1M85.9M74.5M72.6M63.6M
Depreciation and amortization10.9M10.3M10.1M19.4M19.3M18.8M17.1M10.3M
EBITDA11.3M11.7M18.2M34.5M26.2M22.8M(33.3M)2.9M
EBITDA margin, %9.7%8.7%13.2%14.4%14.8%-30.1%1.0%
EBIT363.0K1.4M8.1M15.1M6.9M4.0M(50.4M)(18.2M)
EBIT margin, %1.2%3.9%5.8%3.8%2.6%-45.6%-6.4%
Interest income170.0K766.0K671.0K253.0K157.0K196.0K150.0K
Interest expense347.0K325.0K1.3M3.7M3.9M3.7M6.3M5.9M
Pre tax profit16.0K982.0K7.3M12.1M3.0M461.0K(56.6M)(24.0M)
Income tax expense11.0K195.0K3.0M4.5M1.6M1.5M1.2M(3.0M)
Net Income5.0K787.0K4.3M7.5M1.4M(1.0M)(57.8M)(20.9M)

Footer menu